Q Biomed Inc. to Present at Biotech Showcase(™) 2018

NEW YORK, January 3, 2018 /PRNewswire/ --Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company announced today that Denis Corin, Chief Executive Officer, will present at the Biotech Showcase(™) 2018 Conference to be held January 8 - 10, 2018 in San...

Q BioMed Provides Year End Update

Company Ends Year with an Advancing Full Pipeline and a Catalyst Rich Year AheadNEW YORK, Dec. 21, 2017 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to provide this year end update to its shareholders. The...

Q BioMed Announces Full Settlement of All Convertible Debt

Company Closes Financial Year End With No Outstanding Convertible or Loan Debt NEW YORK, December 5, 2017 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration Company, announced today that all convertible notes and loans have been settled in full,...

Q Biomed looks to dust off shelved cancer pain drug

Denis Corin has spent the last 13 years in the biopharmaceutical industry watching and learning from scientists and companies that fail. “I’ve seen so many promising and innovative young technologies really struggle along or die on the vine because they’re run by...